N-((2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1-pentanamidocyclopentanecarboxamide; SR 49498; Irbesartan impurity A; Irbesartan Related Compound A; USP Irbesartan USP Related Compound; 1-Pentanoylamino-cyclopentanecarboxylic Acid [2'-(1H-Tetrazol-5-yl)-biphenyl-4-ylmethyl]-amide; 1-(Pentanoylamino)-N-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]cyclopentanecarboxamide; N-((2'-(1H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1-pentanamidocyclopentanecarboxamide; Irbesartan EP Impurity A; Irbesartan USP Related Compound A; Irbesartan Metabolite
N-((2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1-pentanamidocyclopentanecarboxamide; SR 49498; Irbesartan impurity A; Irbesartan Related Compound A; USP Irbesartan USP Related Compound; 1-Pentanoylamino-cyclopentanecarboxylic Acid [2'-(1H-Tetrazol-5-yl)-biphenyl-4-ylmethyl]-amide; 1-(Pentanoylamino)-N-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]cyclopentanecarboxamide; N-((2'-(1H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-1-pentanamidocyclopentanecarboxamide; Irbesartan EP Impurity A; Irbesartan USP Related Compound A; Irbesartan Metabolite